These data not only confirm the involvement of CNNM2 and NT5C2 genes in the development of hypertension but also propose the zebrafish model as a potential tool for anti-hypertensive drug screening, allowing to associate drugs treatment with a specific genetic mutation. This evidence concerns the gene CNNM2 and Hypertension.